Antirheumatic agents in covid-19: is IL-6 the right target?

Pier Leopoldo CapecchiPietro Enea LazzeriniLuca VolterraniMaria Antonietta MazzeiBarbara RossettiGiacomo ZanelliDavid BennettElena BargagliFederico FranchiMatteo CameliSerafina ValenteLuca CantariniBruno Frediani

Published in: Annals of the rheumatic diseases (2020)

Keyphrases

coronavirus disease
sars cov
rheumatoid arthritis
rheumatoid arthritis patients
respiratory syndrome coronavirus
disease activity
systemic lupus erythematosus